Brian Corvese - Jun 16, 2021 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/ Adam Krauss, as Attorney-in-Fact for Brian Corvese
Stock symbol
AGEN
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 06:58 PM
Previous filing
Jul 2, 2021
Next filing
Oct 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Options Exercise +22.5K +32.28% 92.1K Jun 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Restricted Stock Unit Options Exercise -16K -50% 16K Jun 16, 2021 Common Stock 16K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 16, 2020, Mr. Corvese was granted 22,471 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Corvese was issued the underlying 22,471 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.
F2 On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.